Cargando...
Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
Multiple myeloma (MM) is an incurable hematological malignancy characterized by the clonal proliferation of neoplastic plasma cells. The use of proteasome inhibitors in the treatment of MM has led to significant improvements in outcomes. This article reviews data on the use of the two approved prote...
Gardado en:
| Publicado en: | Pharmaceuticals (Basel) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4381198/ https://ncbi.nlm.nih.gov/pubmed/25545164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph8010001 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|